SCHEMBL18330879

SCHEMBL18330879

Cc1nccn1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718176 0.72
SCHEMBL28026244 0.72
SCHEMBL28183997 0.71 ALDH1A1 (0.43)
SCHEMBL15149 0.69
SCHEMBL11334103 0.69
SCHEMBL16694847 0.69
SCHEMBL7841754 0.69
SCHEMBL21452448 0.67 KCNH2 (0.36)
SCHEMBL25867853 0.67
SCHEMBL1146945 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109643752-A FLEXIBLE PIEZOELECTRIC AND FERROELECTRIC HALOIMIDAZOLE CRYSTALS 西北大学 2019-04-16 CN claimed
CN-116059968-B Metal organic framework material for propane adsorption and preparation method and application thereof 中国石油化工股份有限公司 2024-09-03 CN disclosed
US-20240018125-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS ERMIUM THERAPEUTICS (FR) 2024-01-18 US disclosed
EP-4289833-A1 TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-12-13 EP disclosed
EP-4273146-A1 TRICYCLIC COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2023-11-08 EP disclosed
US-20230279052-A1 PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES STEALTH BIOTHERAPEUTICS INC. 2023-09-07 US disclosed
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed
US-20230219970-A1 DIHYDROCHROMENE DERIVATIVES Sumitomo Pharma Co., Ltd. (JP) 2023-07-13 US disclosed
CN-116059968-A Metal organic framework material for propane adsorption and preparation method and application thereof 中国石油化工股份有限公司 2023-05-05 CN disclosed
US-11639357-B2 Dihydrochromene derivatives Sumitomo Pharma Co., Ltd. (JP) 2023-05-02 US disclosed
CN-106536507-A 2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use 里格尔药品股份有限公司 2017-03-22 CN disclosed
WO-2017030814-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS Arvinas, Inc. (US) 2017-02-23 WO disclosed
WO-2016205460-A1 POLYCYCLIC DERIVATIVES TARGETING RAL GTPASES AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. (US) 2016-12-22 WO disclosed
CN-104619709-B Imidazopyridine derivatives as modulators of TNF activity UCB生物制药私人有限公司 2016-11-09 CN disclosed
CN-105814055-A Fused imidazole and pyrazole derivatives as modulators of TNF activity UCB生物制药私人有限公司 2016-07-27 CN disclosed
CN-102791713-B Imidazo [1,2-A ] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases JANSSEN PHARMACEUTICA N.V. (BE) 2016-02-03 CN disclosed
CN-102596961-B Imidazo [1,2-b] pyridazine derivatives and the purposes as PDE10 inhibitor thereof JANSSEN PHARMACEUTICA N.V. (BE) 2015-12-02 CN disclosed
CN-104744491-A Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use HOFFMAN LA ROCHE AG 2015-07-01 CN disclosed
CN-102762576-B Benzoxazepine PI3K inhibitor compounds and methods of use HOFFMANN LA ROCHE 2015-04-22 CN disclosed
CN-102762576-A Benzoxazepine PI3K inhibitor compounds and methods of use HOFFMANN LA ROCHE 2012-10-31 CN disclosed